Andrew J. Schwab, Director, 10% Owner at Skye Bioscience, Inc. (SKYE), sold 529,155 shares at $6.06 ($3.5M) on 2024-09-13, disclosed to the SEC on 2024-09-13.
Open-market sale of $3.5M SKYE by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.60 | 1,440 | $10K | 0.3% |
| 2 | $6.60 | 36,504 | $241K | 6.9% |
| 3 | $6.60 | 36,504 | $241K | 6.9% |
| 4 | $6.60 | 214,556 | $1.4M | 40.7% |
| 5 | $6.60 | 214,556 | $1.4M | 40.7% |
| 6 | $6.06 | 79 |
| $479 |
| 0.0% |
| 7 | $6.06 | 2,000 | $12K | 0.3% |
| 8 | $6.06 | 11,758 | $71K | 2.0% |
| 9 | $6.06 | 11,758 | $71K | 2.0% |
| Total | $6.57 avg | 529,155 | $3.5M | 100% |
| Filing → |
| CAMP | SELL | 2026-08-31 | $1.6M | — | Filing → |
| CAMP | SELL | 2026-08-26 | $45 | — | Filing → |
| CAMP | SELL | 2026-08-21 | $880K | — | Filing → |